We read with interest Lara Tavoschi and colleagues' Article on the management of infectious diseases in European prisons. The authors describe the high burden of communicable diseases, including hepatitis C virus (HCV), in European prisons and how prioritising health care in this sector has benefits for both prisoners and the broader community. Similarly, in Australia, there is a disproportionately high HCV seroprevalence among people in prison, reaching up to 50% among those who inject drugs.
